Skip to content

A Clinical Trial To Check The Effect Of Jirak Tail In The Management Of Scabies In Children

A Randomized Open Labelled Controlled Clinical Trial To Evaluate Efficiency Of Jirak Tail In The Management Of Pama With Special Reference To Scabies In Children - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094524
Enrollment
78
Registered
2025-09-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A00-B99- Certain infectious and parasitic diseases Health Condition 2: A00-B99- Certain infectious and parasitic diseases

Interventions

None listed

Sponsors

Dr Harshada Sunil Ahirrao
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Children diagnosed as a case of pama 2 Either male or female patient irrespective of caste and socio economic status 3 Patient of pama (scabies) without any complications 4Patient of both sexes

Exclusion criteria

Exclusion criteria: 1The child suffering from any chronic skin disease, immune suppressed systemic disorder 2 Pama with secondary infection 3 Occurence of any severe malnutrition disorder

Design outcomes

Primary

MeasureTime frame
Jirak Tail Is Effective In The Management of PAMATimepoint: 7 days

Secondary

MeasureTime frame
Permithrin ointment is effective in management of PamaTimepoint: 7 days

Countries

India

Contacts

Public ContactDrDheeraj Shinde

Late Kedari Redekar Ayurvedic Mahavidyalaya post Graduate Research Centre Gadhinglaj

dr.dheeraj26@rediffmail.com9860122355

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026